Navigation Links
STAAR Surgical Reports Strong First Quarter 2013 Financial Results
Date:5/1/2013

ipeline in place for new products throughout this year and well into 2014.  In addition, we have made investments to drive future top line and bottom line growth with our spending to add new sales and marketing positions and our resource dedication to the manufacturing consolidation project.  By maintaining our strong balance sheet, continuing to invest in focused research & development initiatives, and keeping a close eye on operational efficiencies, I believe we can achieve our growth plans for 2013 and beyond," concluded Mr. Caldwell.

Recent Visian Implantable Collamer® Lens (ICL) Highlights

  • ICL sales represented 59.0% of total sales, compared to 55.5% of sales in Q1 2012.
  • ICL sales increased 24% to $10.6 million from $8.6 million in Q1 2012 reflecting an 18% increase in unit sales and a 5% increase in price.
  • Mix between ICL and TICL (Toric ICL) remains approximately 35% of units and 41% of dollars are TICLs.
  • Overall sales in the Company's 11 key markets reflected a 25% increase in revenues.
  • During the recent ASCRS meeting the Company celebrated the following successful ICL implant surgeries:
  • Over 350,000 Visian ICL implants.
  • Nearly 100,000 of the above were the Visian TICL.
  • Over 16,000 of the above were Visian CentraFLOW ICL implants.
  • Also during the ASCRS meeting, over 50 ophthalmic surgeons evaluated and provided feedback to the Company on the new ICL V5 preloaded design.  This product is expected to gain CE Mark approval during the third quarter.
  • Regional ICL UpdatesEurope, Middle East, Africa

  • Europe increased 57% in revenue due to gains from the CentraFLOW technology, and new sales personnel hired in 2012.
  • Spain grew 156% driven by the conversion from a distributor sales model to a direct model.  This provided end customer pricing for the market.  Visian ICL unit growth was 37% for the q
    '/>"/>

  • SOURCE STAAR Surgical Company
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. STAAR Surgical Provides Preliminary First Quarter Revenue Results
    2. STAAR Surgical Announces Fourth Quarter 2012 Results Release Date And Conference Call And Webcast
    3. STAAR Surgical Reports Third Quarter 2012 Financial Results
    4. STAAR Surgical Appoints Charles Slacik To Its Board Of Directors
    5. STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
    6. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
    7. STAAR Surgical To Present At The 32nd Annual Canaccord Growth Conference
    8. STAAR Surgical Reports Second Quarter 2012 Financial Results
    9. STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
    10. STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
    11. B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/20/2014)... SAN DIEGO , Oct. 20, 2014 /PRNewswire/ ... development of therapeutic antibodies, today announced the appointment ... Development Officer. Dr. Londei will lead the preclinical ... "We are pleased to welcome ... Hamza Suria , President and Chief Executive ...
    (Date:10/20/2014)... Mary,s Medicinals today announced that its 501(c)(3) foundation, ... Operation Grow4Vets , a national, nonpartisan organization focused ... to assist them in living with injuries sustained while ... , An ever-increasing number of medical studies have shown ... pain, Post-traumatic Stress Disorder (PTSD) and Traumatic Brain Injury ...
    (Date:10/19/2014)... , Oct. 20, 2014 CTI BioPharma Corp. ... will report its third quarter 2014 financial results on ... U.S. financial markets. Following the announcement, members of the ... discuss the results and provide a general corporate update ... the event can be obtained as follows: ...
    Breaking Medicine Technology:AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 3CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2
    ... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: ... and a live Internet webcast along with a slide presentation ... a.m. PT) to discuss results for the 2010 fourth quarter ... on this call is (877) 295-5743, confirmation code 41335702.  International ...
    ... Pharmaceuticals Inc. ("Joyant"), a privately-held pharmaceutical company, announced the ... class of anti-cancer therapeutics based upon Smac mimetics.  Smac ... pathway and have broad potential for the treatment of ... The United States Patent and Trademark Office (USPTO) granted ...
    Cached Medicine Technology:Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011 2
    (Date:10/20/2014)... National Teen Driver Safety Week is October 19-25, ... Pediatrics (Ohio AAP, http://www.ohioaap.org ) is joining the National ... drivers to talk to their teens and always set the ... are the leading cause of death for U.S. teens. In ... and 859 (42%) of those teen drivers were killed in ...
    (Date:10/20/2014)... It’s hard to imagine what it’s like to live without ... world, it’s a reality. And while new shoes are considered ... walk barefoot on rocky terrain or sewage-lined streets just to ... , Buckner International's Shoes for Orphan Souls ... to encourage support for Air1 and while also providing new ...
    (Date:10/20/2014)... Silver Spring, Maryland, USA (PRWEB) October 20, 2014 ... readers or to track interventions? Here comes a wonderful ... leading mobile app development company helped its ... track Intervention more efficiently. The app is designed for ... iPad, and iPod touch. This app is optimized for ...
    (Date:10/19/2014)... October 20, 2014 Recently, BambooIndustry.com, one ... unveiled its new range of bamboo deckings . ... these natural items; they are now available at deeply ... people, it is hard to overstate the significance of ... attention to online services. The company’s workers are striving ...
    (Date:10/19/2014)... (PRWEB) October 20, 2014 Having been working ... a good knowledge of customer needs. According to James, one ... covered with dazzling sequins, or with high-low skirts that add ... a huge demand. Recently, LunaDress has unveiled its new selection ... of fact, the company’s brand new items are available in ...
    Breaking Medicine News(10 mins):Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2
    ... 12 HOUR for use in treating symptoms of seasonal allergic ... a combination of desloratadine 2.5 mg and pseudoephedrine sulfate, USP ... in persons above 12 years of age. The drug ... non-nasal symptoms occurring due to seasonal allergic rhinitis. Two ...
    ... India’s National Institute of Immunology are reported to have ... how the tuberculosis (TB) bacteria survives in the human ... and more effective medicines to combat the disease, which ... world annually. The research team led by Rajesh S. ...
    ... new survey has found that many British workers are not averse ... be sent in by text messages or the typical cough and ... is the widespread dissatisfaction with holiday allowance for British workers, who ... ,'Early February is a very popular time for ...
    ... leaders, particularly in South Asia to prohibit smoking among the ... the British Medical Journal (BMJ). The help of the Muslim ... ,The researchers analyzed data on the prevalence of smoking ... Smoking rates in each of these countries is significantly higher ...
    ... topic for several years, gaining momentum over the past one ... physiological responses to them. A new study, published in the ... effect of types of placebo devices Vs pills on patients ... placebos to gauge the effectiveness of novel treatment methods, but ...
    ... of Health said that conventional tests fail to identify smaller blood ... sign because they do not have the bulky clogs in main ... shortness of breath and are at an increased risk of a ... is very common among both men and women and causes maximum ...
    Cached Medicine News:Health News:Placing a Finger on Responses to Placebo Types 2
    ... surface preparation is the Leica SM2500 sledge ... ,Ultramilling is often a viable alternative to ... preparation. Especially with difficult specimens, where hard ... side in one specimen block, the results ...
    ... The Trellis Infusion Catheter enables the physician ... physician-specified fluid, and disperse the agent by ... The Trellis is a multi-lumen catheter with ... end and infusion holes located between these ...
    ... The SENSAR® Acrylic IOL with OptiEdge ... performance, long-term refractive stability, and excellent handling. ... has had no reports of vacuoles; the ... internal reflections and provide 360 degrees of ...
    ... acrylic foldable single-piece posterior chamber lenses are ... human crystalline lens in the visual correction ... age and older. The optical portion consists ... material. These lenses have biconvex optics and ...
    Medicine Products: